跳至主要内容
临床试验/NCT05469607
NCT05469607招募中不适用

The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD

Austin Health2 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2022年7月8日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Austin Health
入组人数
13
试验地点
2
主要终点
Safety and efficacy based on endoscopic recurrence

研究概览

简要总结

The purpose of this study is to evaluate the safety of vagal nerve neuromodulation in a cohort of patients operated on for Crohn's disease, in a prospective, single centre, cohort study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All patients aged 18 years or older with Crohn's disease who undergo resection with an endoscopically accessible primary anastomosis which results in macroscopic normality.
  • Patients having a reversal of a temporary ileostomy created after previous surgery for Crohn's disease may be enrolled provided that the reversal of the ileostomy results in a primary anastomosis and macroscopic normality of the remaining bowel.
  • Patients with co-existing perianal disease may be included provided the resection has led to a primary anastomosis and macroscopic normality of the intestine.
  • Patients must have proven history of Crohn's disease based on (clinical, radiologic, endoscopic and histologic criteria).

排除标准

  • Patients with anastomosis which is endoscopically inaccessible by standard colonoscopy.
  • Patients in whom there is persisting macroscopic abnormality post-surgical resection.
  • Patients with Crohn's disease who have an end stoma (ileostomy or colostomy).
  • Patients for whom endoscopy is not suitable due to co-morbidities or unwell clinical state
  • Inability to give informed consent.
  • Inability to obtain access to the anastomosis at colonoscopy.
  • Suspected perforation of the gastrointestinal tract.
  • Patients who are pregnant or breastfeeding.

结局指标

主要结局

Safety and efficacy based on endoscopic recurrence

时间窗: 6 months post-operation

Recurrence defined as the presence of any aphthous ulcers, and severe recurrence defined as an endoscopic Rutgeerts score ≥ 2 (5 aphthous ulcers or larger ulcers confined to the anastomosis)

次要结局

  • Surgical recurrence(6 and 18 months post-operation)
  • Clinical recurrence(6 months and 18 months post-operation)
  • Endoscopic recurrence(18 months post-operation)

研究者

发起方
Austin Health
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Dr Peter De Cruz

Head of Inflammatory Bowel Disease Unit

Austin Health

研究点 (2)

Loading locations...

相似试验